共 50 条
- [41] 2013 Update of the American Society of Clinical Oncology/College of American Pathologists Guideline for Human Epidermal Growth Factor Receptor 2 Testing: Impact on Immunohistochemistry-Negative Breast CancersJOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (17) : 1856 - 1857Lambein, KathleenVan Bockstal, MiekeDenys, HanneloreLibbrecht, Louis
- [42] American Society of Clinical Oncology/College of American Pathologists Human Epidermal Growth Factor Receptor 2 Testing Clinical Practice Guideline Upcoming Modifications Proof That Clinical Practice Guidelines Are Living DocumentsARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2015, 139 (08) : 970 - 971Hammond, M. Elizabeth H.Hicks, David G.
- [43] Implications of the Updated 2013 American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations on Human Epidermal Growth Factor Receptor 2 Gene Testing Using Immunohistochemistry and Fluorescence In Situ Hybridization for Breast CancerARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2016, 140 (02) : 140 - 147Lim, Tse HuiLim, Alvin Soon TiongThike, Aye AyeTien, Sim LengTan, Puay Hoon
- [44] Prognostic value of sarcopenia in patients with lung cancer treated with epidermal growth factor receptor tyrosine kinase inhibitors or immune checkpoint inhibitorsFRONTIERS IN NUTRITION, 2023, 10Lyu, JiahuaYang, NingjingXiao, LingNie, XinyuXiong, JingLiu, YudiZhang, MinZhang, HangyueTang, CunhanPan, ShiyiLiang, LongBai, HansongLi, ChurongKuang, HaoLi, Tao
- [45] Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors for Non-Small-Cell Lung Cancer Patients with Leptomeningeal CarcinomatosisJOURNAL OF THORACIC ONCOLOGY, 2015, 10 (12) : 1754 - 1761Liao, Bin-ChiLee, Jih-HsiangLin, Chia-ChiChen, Ya-FangChang, Chin-HaoHo, Chao-ChiShih, Jin-YuanYu, Chong-JenYang, James Chih-Hsin
- [46] Skin Toxicities Induced by Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors and their Influence on Treatment Adjustments in Lung Cancer PatientsACTA DERMATO-VENEREOLOGICA, 2024, 104Lee, Ji SuWoo, JiminKim, Tae MinKim, NamkyuKeam, BhumsukJo, Seong Jin
- [47] Association of Polymorphisms in Inflammation Genes With the Prognosis of Advanced Non-Small Cell Lung Cancer Patients Receiving Epidermal Growth Factor Receptor Tyrosine Kinase InhibitorsFRONTIERS IN ONCOLOGY, 2022, 12Zhang, XuelinYe, TengfeiLi, MingdongYan, HongwangLin, HuiLu, HongshengQi, ZechengSheng, HaihuiHe, Chunya
- [48] 2013 Update of the American Society of Clinical Oncology/College of American Pathologists Guideline for Human Epidermal Growth Factor Receptor 2 Testing: Impact on Immunohistochemistry-Negative Breast Cancers ReplyJOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (17) : 1857 - 1859Wolff, Antonio C.Hammond, M. Elizabeth H.Hicks, David G.Dowsett, MitchHayes, Daniel F.McShane, Lisa M.
- [49] American Society of Clinical Oncology Provisional Clinical Opinion: Epidermal Growth Factor Receptor (EGFR) Mutation Testing for Patients With Advanced Non-Small-Cell Lung Cancer Considering First-Line EGFR Tyrosine Kinase Inhibitor TherapyJOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15) : 2121 - 2127Keedy, Vicki LeighTemin, SarahSomerfield, Mark R.Beasley, Mary BethJohnson, David H.McShane, Lisa M.Milton, Daniel T.Strawn, John R.Wakelee, Heather A.Giaccone, Giuseppe
- [50] Clinical Definition of Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-Small-Cell Lung CancerJOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (02) : 357 - 360Jackman, DavidPao, WilliamRiely, Gregory J.Engelman, Jeffrey A.Kris, Mark G.Jaenne, Pasi A.Lynch, ThomasJohnson, Bruce E.Miller, Vincent A.